Physician profile
Morgan E Pope
NPI 1760105225
$2,643.52
in general payments reported to CMS, 2019-2025
8 companies · $62.01 in 2025
The $62.01 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $19.73 · 2024: $2,562 · 2025: $62.01.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,381 · Food and Beverage: $1,262.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,381.12 |
| Food and Beverage | $1,262.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,481.11 | 2024-2025 | Micra |
| Boston Scientific Corporation | $55.86 | 2024 | Watchman Flx |
| E.R. Squibb & Sons, L.L.C. | $19.73 | 2023 | Eliquis |
| Cvrx, INC. | $19.52 | 2024 | Barostim Neo System |
| Alnylam Pharmaceuticals INC. | $19.36 | 2025 | Amvuttra |
| Daxor Corporation | $17.18 | 2024 | Bva-100 |
| Janssen Pharmaceuticals, INC | $16.11 | 2024 | Xarelto |
| Novo Nordisk INC | $14.65 | 2025 | Wegovy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Morgan Pope listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.